Digital Innovation
Leading technological innovation
Automation, artificial intelligence (AI) and machine learning are revolutionizing many industries enabling increased productivity, improved quality and enhancing return on investment. The pharmaceutical industry is still largely relying on established, but increasingly outdated, systems and methodologies that were efficient many years ago yet now prove to be a limiting factor in innovation and growth. At PharmaLex we combine our extensive global experience and deep understanding of pharmaceutical lifecycle processes with the development of our cloud-based platform for life sciences automation alongside key partnerships with leading technology vendors. Through our pharma technology-enabled services we are helping our customers to adopt and take advantage of innovative technologies to drive efficiency gains within their own operations.
Most pharmaceutical companies have the raw ingredients at their fingertips – mass volumes of valuable historical data that can be analyzed to predict future outcomes. At PharmaLex we have the technology, know-how and experience to take these raw ingredients and realize real, immediate and lasting benefits for our clients – we call this SMARTPHLEX.
Utilizing our strategic and clinical expertise to drive efficiency gains during the earliest phase of development
PharmaLex continually engages with Key Opinion Leaders and scientific experts across the industry to identify opportunities where technology could lead to faster market approval or automated post-market surveillance. Twice nominated by CPhI for our innovative use of technology, we consider this approach to be essential in future proofing our industry.
Our PharmaLex.perts are currently working on developing a number of exciting solutions to bring cutting edge technology to early phase activities. Once tested we will launch them here, so watch this space!
Resources
Whitepaper:
What is preventing us from providing electronic product information and how industry can support the wider ePI project?
Survey:
Disruptive Technologies in Life Sciences (DTLS) consortium – annual survey results